Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution plays a significant role in shaping the dynamics of the coronavirus disease 2019 pandemic. To monitor the evolution of SARS-CoV-2 variants, through international collaborations, we performed genomic epidemiology analyses on a weekly basis with SARS-CoV-2 samples collected from a border region between Germany, Poland, and the Czech Republic in a global background. For identified virus mutant variants, active viruses were isolated and functional evaluations were performed to test their replication fitness and neutralization sensitivity against vaccine-elicited serum neutralizing antibodies. Thereby we identified a new B.1.1.7 sub-lineage carrying additional mutations of nucleoprotein G204P and open-reading-frame-8 K68stop. Of note, this B.1.1.7 sub-lineage is the predominant B.1.1.7 variant in several European countries such as Czech Republic, Austria, and Slovakia. The earliest samples belonging to this sub-lineage were detected in November 2020 in a few countries in the European continent, but not in the UK. We have also detected its further evolution with extra spike mutations D138Y and A701V, which are signature mutations shared with the Gamma and Beta variants, respectively. Antibody neutralization assay of virus variant isolations has revealed that the variant with extra spike mutations is 3.2-fold less sensitive to vaccine-elicited antibodies as compared to the other B.1.1.7 variants tested, indicating potential for immune evasion, but it also exhibited reduced replication fitness, suggesting lower transmissibility. The wide spread of this B.1.1.7 sub-lineage was related to the pandemic waves in early 2021 in various European countries. These findings about the emergence, spread, evolution, infection, and transmission abilities of this B.1.1.7 sub-lineage add to our understanding about the pandemic development in Europe and highlight the importance of international collaboration on virus mutant surveillance.
Article activity feed
-
-
SciScore for 10.1101/2021.11.01.21265749: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Confluent Vero E6 cells seeded the day before were infected with the virus-containing serum dilutions for 1 h at 37°C and 5% CO2 with occasional shaking. Vero E6suggested: NoneSoftware and Algorithms Sentences Resources The pipeline includes several Python scripts that manage the analysis workflow. Pythonsuggested: (IPython, RRID:SCR_001658)Briefly, it allows for the filtering of genomes, the alignment of genomes in MAFFT (14), phylogenetic tree inference in IQ-Tree (15), tree dating (16) and ancestral state construction and annotation. MAFFTsuggested: (MAFFT, RRID:SCR_011811)IQ-Treesu…SciScore for 10.1101/2021.11.01.21265749: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Confluent Vero E6 cells seeded the day before were infected with the virus-containing serum dilutions for 1 h at 37°C and 5% CO2 with occasional shaking. Vero E6suggested: NoneSoftware and Algorithms Sentences Resources The pipeline includes several Python scripts that manage the analysis workflow. Pythonsuggested: (IPython, RRID:SCR_001658)Briefly, it allows for the filtering of genomes, the alignment of genomes in MAFFT (14), phylogenetic tree inference in IQ-Tree (15), tree dating (16) and ancestral state construction and annotation. MAFFTsuggested: (MAFFT, RRID:SCR_011811)IQ-Treesuggested: (IQ-TREE, RRID:SCR_017254)Graphs were generated using GraphPad Prism 9. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your code and data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-